Ownership history in Frazier Life Sciences Management, L.P. · 7 quarters on record
This page tracks every 13F SEC filing in which Frazier Life Sciences Management, L.P. reported a position in ERASCA INC (ERAS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | UNCHANGED | 22,729,436 | — | 0% | 2.27% | $84.6M | $3.72 |
| 2025 Q3 | UNCHANGED | 22,729,436 | — | 0% | 1.48% | $49.6M | $2.18 |
| 2025 Q2 | ADDED | 22,729,436 | +153,585 | +0.7% | 1.15% | $28.9M | $1.27 |
| 2025 Q1 | ADDED | 22,575,851 | +3,184,164 | +16.4% | 1.41% | $30.9M | $1.37 |
| 2024 Q4 | UNCHANGED | 19,391,687 | — | 0% | 2.02% | $48.7M | $2.51 |
| 2024 Q3 | ADDED | 19,391,687 | +3,175,471 | +19.6% | 2.12% | $52.9M | $2.73 |
| 2024 Q2 | INITIATED | 16,216,216 | — | — | 1.79% | $38.3M | — |
As of 2025 Q4 — sorted by position size